Literature DB >> 16676316

Study of the phase I and phase II metabolism of nephrotoxin aristolochic acid by liquid chromatography/tandem mass spectrometry.

Wan Chan1, Liang Cui, Guowang Xu, Zongwei Cai.   

Abstract

Prolonged exposure to aristolochic acid (AA) was shown to pose rapid progressive renal fibrosis in Belgian women in a slimming regime in the early 1990s. AA was also demonstrated to be strong carcinogen in rats. The carcinogenicity of AA is generally believed to be related to the nitro-reduction of AA, in which the aristolactam-nitriumion ion with a delocalized positive charge is the ultimate carcinogen. In this study, the phase I and phase II metabolism of AA was investigated by using an in vitro system with rat liver S9 and an in vivo animal study with Sprague-Dawley rats. AA was found to have been undergone hydroxylation, lactam formation, and desnitro and desmethyl transformations. Three conjugated metabolites of AA, namely the N- and O-glucuronides of aristolactams, were detected directly in pre-concentrated urine sample, with no acid hydrolysis or enzymatic digestion. Structural elucidation of the metabolites was performed by using liquid chromatography/tandem mass spectrometry (LC/MS/MS). The results indicated that N-glucuronidation was the major phase II metabolic pathway for the aristolactams formed by AA after their nitro-reduction. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16676316     DOI: 10.1002/rcm.2513

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  20 in total

Review 1.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

2.  Liquid chromatography-tandem mass spectrometry analysis of the DNA adducts of aristolochic acids.

Authors:  Wan Chan; Yufang Zheng; Zongwei Cai
Journal:  J Am Soc Mass Spectrom       Date:  2007-01-05       Impact factor: 3.109

3.  Aristolochic acid I metabolism in the isolated perfused rat kidney.

Authors:  Horacio A Priestap; M Cecilia Torres; Robert A Rieger; Kathleen G Dickman; Tomoko Freshwater; David R Taft; Manuel A Barbieri; Charles R Iden
Journal:  Chem Res Toxicol       Date:  2011-12-14       Impact factor: 3.739

4.  Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2.

Authors:  Marie Stiborová; Katerina Levová; Frantisek Bárta; Zhanquan Shi; Eva Frei; Heinz H Schmeiser; Daniel W Nebert; David H Phillips; Volker M Arlt
Journal:  Toxicol Sci       Date:  2011-11-15       Impact factor: 4.849

5.  Physiological and molecular characterization of aristolochic acid transport by the kidney.

Authors:  Kathleen G Dickman; Douglas H Sweet; Radha Bonala; Tapan Ray; Amy Wu
Journal:  J Pharmacol Exp Ther       Date:  2011-05-05       Impact factor: 4.030

6.  In-line formation and identification of toxic reductive metabolites of aristolochic acid using electrochemistry mass spectrometry coupling.

Authors:  Ugo Bussy; Renaud Boisseau; Mikaël Croyal; Ranil C T Temgoua; Mohammed Boujtita
Journal:  Anal Bioanal Chem       Date:  2022-01-13       Impact factor: 4.142

Review 7.  High-performance liquid chromatography-tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites.

Authors:  M Holcapek; L Kolárová; M Nobilis
Journal:  Anal Bioanal Chem       Date:  2008-03-15       Impact factor: 4.142

8.  Sulfotransferase-1A1-dependent bioactivation of aristolochic acid I and N-hydroxyaristolactam I in human cells.

Authors:  Keiji Hashimoto; Irina N Zaitseva; Radha Bonala; Sivaprasad Attaluri; Katherine Ozga; Charles R Iden; Francis Johnson; Masaaki Moriya; Arthur P Grollman; Viktoriya S Sidorenko
Journal:  Carcinogenesis       Date:  2016-04-18       Impact factor: 4.944

9.  Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents.

Authors:  Shinya Shibutani; Radha R Bonala; Thomas Rosenquist; Robert Rieger; Naomi Suzuki; Francis Johnson; Frederick Miller; Arthur P Grollman
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

10.  Aristolochic acid IVa forms DNA adducts in vitro but is non-genotoxic in vivo.

Authors:  Jingjing Wan; Ruixue Chen; Zhou Yang; Jing Xi; Yiyi Cao; Yu Chen; Xinyu Zhang; Yang Luan
Journal:  Arch Toxicol       Date:  2021-07-05       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.